HISTALOG 50 mg/ml injektioneste Finnland - finnska - Fimea (Suomen lääkevirasto)

histalog 50 mg/ml injektioneste

eli lilly and company - betazoli hydrochloridum - injektioneste - 50 mg/ml - betatsoli

HUMULIN REGULAR 40 IU/ml injektioneste Finnland - finnska - Fimea (Suomen lääkevirasto)

humulin regular 40 iu/ml injektioneste

eli lilly and company - insulinum ihmisen - injektioneste - 40 iu/ml - ihmisinsuliini

HUMULIN NPH 40 IU/ml injektioneste Finnland - finnska - Fimea (Suomen lääkevirasto)

humulin nph 40 iu/ml injektioneste

eli lilly and company - insulinum ihmisen - injektioneste - 40 iu/ml - ihmisinsuliini

Verzenios Evrópusambandið - finnska - EMA (European Medicines Agency)

verzenios

eli lilly nederland b.v. - abemaciclib - rintojen kasvaimet - antineoplastiset aineet - early breast cancerverzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, node positive early breast cancer at high risk of recurrence (see section 5. in pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (lhrh) agonist. advanced or metastatic breast cancerverzenios is indicated for the treatment of women with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. in pre- or perimenopausal women, the endocrine therapy should be combined with a lhrh agonist.

Lyumjev (previously Liumjev) Evrópusambandið - finnska - EMA (European Medicines Agency)

lyumjev (previously liumjev)

eli lilly nederland b.v. - lisproinsuliini - diabetes mellitus - diabeetilla käytettävät lääkkeet - diabetes mellituksen hoito aikuisilla, nuorilla ja yli 1-vuotiailla lapsilla. diabetes mellituksen hoito aikuisilla.

Jaypirca Evrópusambandið - finnska - EMA (European Medicines Agency)

jaypirca

eli lilly nederland b.v. - pirtobrutinib - lymfooma, mantle-cell - proteiinikinaasin estäjät - treatment of mantle cell lymphoma (mcl).

Jardiance Evrópusambandið - finnska - EMA (European Medicines Agency)

jardiance

boehringer ingelheim international gmbh - empagliflozin - diabetes mellitus, type 2; heart failure; renal insufficiency, chronic - diabeetilla käytettävät lääkkeet - type 2 diabetes mellitusjardiance is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered in addition to other medicinal products for the treatment of diabetesfor study results with respect to combinations of therapies, effects on glycaemic control, and cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 ja 5. of the annex. heart failurejardiance is indicated in adults for the treatment of symptomatic chronic heart failure.  chronic kidney diseasejardiance is indicated in adults for the treatment of chronic kidney disease.

VANCOCIN 125 mg kapseli, kova Finnland - finnska - Fimea (Suomen lääkevirasto)

vancocin 125 mg kapseli, kova

eli lilly finland oy ab - vancomycini hydrochloridum - kapseli, kova - 125 mg - vankomysiini

FONTEX 20 mg kapseli, kova Finnland - finnska - Fimea (Suomen lääkevirasto)

fontex 20 mg kapseli, kova

eli lilly finland oy ab - fluoxetini hydrochloridum - kapseli, kova - 20 mg - fluoksetiini

CINOBACTIN 500 mg kapseli, kova Finnland - finnska - Fimea (Suomen lääkevirasto)

cinobactin 500 mg kapseli, kova

eli lilly italia s.p.a. - cinoxacinum - kapseli, kova - 500 mg - sinoksasiini